AbbVie (ABBV)
(Real Time Quote from BATS)
$193.74 USD
+0.27 (0.14%)
Updated Sep 23, 2024 02:56 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for AbbVie Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 12,816 | 9,229 | 9,830 | 8,479 | 39,924 |
Receivables | 11,155 | 11,254 | 9,977 | 8,822 | 5,428 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4,099 | 3,579 | 3,128 | 3,310 | 1,813 |
Other Current Assets | 4,932 | 4,401 | 4,993 | 3,562 | 2,354 |
Total Current Assets | 33,002 | 28,463 | 27,928 | 24,173 | 49,519 |
Net Property & Equipment | 4,989 | 4,935 | 5,110 | 5,248 | 2,962 |
Investments & Advances | 304 | 241 | 277 | 293 | 93 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 87,903 | 99,595 | 108,330 | 116,000 | 34,253 |
Deposits & Other Assets | 8,513 | 5,571 | 4,884 | 4,851 | 2,288 |
Total Assets | 134,711 | 138,805 | 146,529 | 150,565 | 89,115 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 30,650 | 25,402 | 22,699 | 20,159 | 11,832 |
Current Portion Long-Term Debt | 7,191 | 4,136 | 12,495 | 8,502 | 3,753 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 37,841 | 29,538 | 35,194 | 28,661 | 15,585 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1,952 | 2,190 | 3,009 | 3,646 | 1,130 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 52,194 | 59,135 | 64,189 | 77,554 | 62,975 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 32,327 | 30,655 | 28,701 | 27,607 | 17,597 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 124,314 | 121,518 | 131,093 | 137,468 | 97,287 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 18 | 18 | 18 | 18 | 18 |
Capital Surplus | 20,180 | 19,245 | 18,305 | 17,384 | 15,193 |
Retained Earnings | -1,000 | 4,784 | 3,127 | 1,055 | 4,717 |
Other Equity | -2,268 | -2,166 | -2,871 | -3,096 | -3,596 |
Treasury Stock | 6,533 | 4,594 | 3,143 | 2,264 | 24,504 |
Total Shareholder's Equity | 10,397 | 17,287 | 15,436 | 13,097 | -8,172 |
Total Liabilities & Shareholder's Equity | 134,711 | 138,805 | 146,529 | 150,565 | 89,115 |
Total Common Equity | 10,397 | 17,287 | 15,436 | 13,097 | -8,172 |
Shares Outstanding | 1,800.00 | 1,768.40 | 1,767.10 | 1,765.40 | 1,478.80 |
Book Value Per Share | 5.78 | 9.78 | 8.74 | 7.42 | -5.53 |
Fiscal Year End for AbbVie Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 13,157 | 18,069 | 12,816 | 13,290 | 8,766 |
Receivables | 11,724 | 11,949 | 11,155 | 11,412 | 11,491 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4,218 | 4,245 | 4,099 | 3,981 | 4,055 |
Other Current Assets | 4,717 | 4,608 | 4,932 | 4,541 | 4,540 |
Total Current Assets | 33,816 | 38,871 | 33,002 | 33,224 | 28,852 |
Net Property & Equipment | 5,023 | 4,980 | 4,989 | 4,934 | 4,943 |
Investments & Advances | 272 | 305 | 304 | 275 | 288 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 93,629 | 95,651 | 87,903 | 90,694 | 95,086 |
Deposits & Other Assets | 9,197 | 9,067 | 8,513 | 7,094 | 6,198 |
Total Assets | 141,937 | 148,874 | 134,711 | 136,221 | 135,367 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 29,329 | 31,326 | 30,650 | 29,658 | 27,036 |
Current Portion Long-Term Debt | 12,586 | 10,196 | 7,191 | 5,115 | 5,203 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 41,915 | 41,522 | 37,841 | 34,773 | 32,239 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2,726 | 2,722 | 1,952 | 2,044 | 2,124 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 58,048 | 63,805 | 52,194 | 55,631 | 55,812 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 32,427 | 32,327 | 31,644 | 32,294 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 135,116 | 140,827 | 124,314 | 124,092 | 122,469 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 18 | 18 | 18 | 18 | 18 |
Capital Surplus | 20,879 | 20,656 | 20,180 | 20,021 | 19,839 |
Retained Earnings | -3,768 | -2,384 | -1,000 | 933 | 1,789 |
Other Equity | -2,470 | -2,414 | -2,268 | -2,318 | -2,220 |
Treasury Stock | 7,838 | 7,829 | 6,533 | 6,525 | 6,528 |
Total Shareholder's Equity | 6,821 | 8,047 | 10,397 | 12,129 | 12,898 |
Total Liabilities & Shareholder's Equity | 141,937 | 148,874 | 134,711 | 136,221 | 135,367 |
Total Common Equity | 6,821 | 8,047 | 10,397 | 12,129 | 12,898 |
Shares Outstanding | 1,766.30 | 1,765.80 | 1,800.00 | 1,765.50 | 1,764.20 |
Book Value Per Share | 3.86 | 4.56 | 5.78 | 6.87 | 7.31 |